CRD-3874

N/A

Report date: 2026/03/13 20:02:36
NME

Base Information

Drug NameCRD-3874
Drug Alias NameCRD3874-SICRD-3874CRD3874
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionStimulator of interferon genes stimulants
TargetsStimulator of interferon genes
Therapy Area/IndicationsSarcomaLeukemia, Myeloid, AcuteCarcinoma, Merkel Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer CenterCuradev Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCuradev Pharma LtdMemorial Sloan Kettering Cancer Center
Inactive CompaniesUniversity Of Maryland, Baltimore
Active IndicationsSarcomaCarcinoma, Merkel Cell
Inactive IndicationsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A